VIR
NASDAQStockVir Biotechnology, Inc.
$9.59-0.23 (-2.39%)
52-Week Range
$4.28
$10.00
Key Stats
Market Cap
1.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.71
Volume
2.7M
Avg Volume
6.3M
Performance
1M
+30.76%
3M
+46.79%
6M
+105.01%
YTD
+65.32%
1Y
+34.06%
3Y
-58.25%
5Y
-81.15%
Price Chart
ETF Exposure
VIR is held by 97 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GERM | ETFMG Treatments, Testing and Advancements ETF | 2.79% |
| MOM | AGFiQ U.S. Market Neutral Momentum Fund | 2.26% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.09% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.96% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.74% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 0.68% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.58% |
| XBI | State Street SPDR S&P Biotech ETF | 0.28% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.21% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.18% |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.17% |
| ESIX | State Street SPDR S&P SmallCap 600 ESG ETF | 0.12% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.12% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.10% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.10% |
| PLTL | Principal US Small-Cap Adaptive Multi-Factor ETF | 0.09% |
| SLYV | State Street SPDR S&P 600 Small Cap Value ETF | 0.09% |
| IJS | iShares S&P Small-Cap 600 Value ETF | 0.09% |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.09% |
| IBB | iShares Biotechnology ETF | 0.08% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.08% |
| IJR | iShares Core S&P Small-Cap ETF | 0.07% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.07% |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 0.07% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.07% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.06% |
| IWN | iShares Russell 2000 Value ETF | 0.06% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 0.06% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.06% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.05% |
| SAA | ProShares - Ultra SmallCap600 | 0.05% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 0.05% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.05% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.04% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.04% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.04% |
| PWS | Pacer WealthShield ETF | 0.03% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.03% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.03% |
| IWM | iShares Russell 2000 ETF | 0.03% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.03% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% |
| VBK | Vanguard Small-Cap Growth ETF | 0.03% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.02% |
| RSSL | Global X - Russell 2000 ETF | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.02% |
| URTY | ProShares - UltraPro Russell2000 | 0.02% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% |
Page 1 of 2Next
About VIR ETF Exposure
Vir Biotechnology, Inc. (VIR) is held by 97 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.3B, VIR is a widely held institutional stock. The stock currently trades at $9.59. Investors can gain exposure to VIR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VIR, sorted by portfolio weight.